Study Suggests Increased Access to MOUDs in Prison Can Lead to Fewer Relapses after Release
Author: (Reviewed by Margaret Moreland).
Source: Volume 25, Number 03, Summer 2024 , pp.51-52(2)
< previous article |next article > |return to table of contents
Abstract:
Contributing editor Margaret Moreland reviews a recent paper by Benjamin J. Bovell-Ammon, Shapei Yan, Devon Dunn, Elizabeth A. Evans, Peter D. Friedmann, Alexander Y. Walley, and Marc R. LaRochelle in the JAMA Network Open, “Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes,” which suggests that increased access to medications for opioid use disorders in prison can lead to fewer relapses after release.Keywords: Medications for Opioid Use Disorder; Buprenorphine
Affiliations:
1: Contributing Editor.